Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2wgj | VGH | Hepatocyte growth factor receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2wgj | VGH | Hepatocyte growth factor receptor | 2.7.10.1 | 1.000 | |
| 4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.628 | |
| 3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.622 | |
| 4ap7 | F47 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.592 | |
| 3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.575 | |
| 4deg | 0JJ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.568 | |
| 4gg5 | 0J3 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.549 | |
| 3zxz | KRW | Hepatocyte growth factor receptor | 2.7.10.1 | 0.543 | |
| 4aoi | 4K0 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.531 | |
| 3zc5 | W9Z | Hepatocyte growth factor receptor | 2.7.10.1 | 0.529 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.487 | |
| 3zbx | 6XE | Hepatocyte growth factor receptor | 2.7.10.1 | 0.483 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.474 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.474 | |
| 5cwa | 0GA | Anthranilate synthase component 1 | 4.1.3.27 | 0.472 | |
| 2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.466 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.462 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.461 | |
| 3s1d | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.461 | |
| 4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
| 3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.458 | |
| 4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.458 | |
| 3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.457 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.456 | |
| 2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
| 1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 1rx8 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.453 | |
| 5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.450 | |
| 1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.450 | |
| 3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.450 | |
| 1q1r | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.449 | |
| 3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.449 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.448 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.447 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
| 4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.447 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.447 | |
| 4at3 | LTI | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.446 | |
| 1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.445 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.445 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3gwf | FAD | Cyclohexanone monooxygenase | / | 0.445 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.443 | |
| 4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.443 | |
| 1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3i81 | EBI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.442 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.441 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.441 | |
| 2w1g | L0G | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 3bht | MFR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.441 | |
| 4a8v | 2AN | Major pollen allergen Bet v 1-J | / | 0.441 | |
| 4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.441 | |
| 4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.441 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.440 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 |